Reddy's will infringe on Lunesta's patent: US court

The United States Court of Appeals for the Federal Circuit has ruled that Dr Reddy's Laboratories Ltd will (rpt will) infringe on the patent of Sunovion Pharmaceuticals blockbuster drug Lunesta.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news